An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
Clinical trial NCT07232537 · RECRUITING
Trial details
- NCT number
- NCT07232537
- Sponsor
- Bayer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-11-20
- Primary completion
- 2027-09-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.